Related content

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

By van Hoogmoed D   Fransen J   Repping-Wuts H   Spee L   Bleijenberg G   van Riel PLCM  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Surgery in rheumatoid arthritis patients under anti-TNF-α therapy: what is the risk?

By Wendling Daniel  

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1396-1397

Springer Publishing Company

Access to resources Recommend Favorite

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

By Bijl Arie   Breedveld Ferdinand   Antoni Christian   Kalden Joachim   Kary Sonja   Burmester Gerd   Beckmann Christina   Unnebrink Kristina   Kupper Hartmut  

Clinical Rheumatology, Vol. 27, Iss. 8, 2008-08 ,pp. : 1021-1028

Springer Publishing Company

Access to resources Recommend Favorite

Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis

By Park M-C.   Jung S-J.   Park Y-B.   Lee S-K.  

Scandinavian Journal of Rheumatology, Vol. 37, Iss. 3, 2008-01 ,pp. : 173-178

Informa Healthcare

Access to resources Recommend Favorite

Tumour necrosis factor- (TNF-) levels and influence of −308 TNF- promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis

By Cuchacovich M   Ferreira L   Aliste M   Soto L   Cuenca J   Cruzat A   Gatica H   Schiattino I   Pérez C   Aguirre A   Salazar-Onfray F   Aguillón JC  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 228-232

Informa Healthcare

Access to resources Recommend Favorite